AIM
NVCR icon

AXA Investment Managers’s NovoCure NVCR Stock Holding History

AXA Investment Managers’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.8M Buy
+371,773
New +$4.97M 0.01% 580

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AXA Investment Managers's NVCR Position: Q3 2025 in Review

AXA Investment Managers opened a new position in NovoCure (NVCR) in Q3 2025: 371,773 shares worth $4.8M. The stake represents 0.01% of the portfolio and ranks #580 among its holdings.

244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • AXA Investment Managers held 371,773 shares of NovoCure worth $4.8M as of Q3 2025.
  • NovoCure was a new AXA Investment Managers position in Q3 2025.
  • NovoCure made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #580 holding.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.